Dalton Medicinal Chemistry will utilize their proprietary insights to design and synthesize several novel classes of compounds against selected riboswitch targets. BioRelix will advance these compounds using their
The new Juvenile Diabetes Research Foundation (JDRF)-Lilly project will support research on biomarkers for pancreatic beta cell mass and function. The JDRF-Lilly Innovative and Academic Research and Development
R84 is a selective, fully human monoclonal antibody that blocks the cancer-promoting agent vascular endothelial growth factor. The study results showed that tumor-associated macrophages are reduced after R84
The Entelos cardiovascular PhysioLab platform is a predictive computer model that simulates patients and drug effects, and represents key biological mechanisms and disease processes that can help to
Results of company’s ocular discovery program suggest that sonepcizumab may be a valuable therapeutic in the treatment of diabetic retinopathy, dry age-related macular degeneration(AMD), uveitis, and scar formation
Zyrtec-D, an over-the-counter version of Zyrtec, has been approved for the relief of symptoms due to hay fever or other upper respiratory allergies such as runny nose, sneezing,
First, Nastech plans to concentrate its resources on its Phase II clinical development programs that are currently ongoing or planned including PYY3-36 nasal spray for obesity, insulin nasal
Under the terms of the merger agreement, Tutogen shareholders will receive 1.22 shares of newly issued RTI common stock in exchange for each share of Tutogen common stock
UK-based GW Pharmaceuticals said that Sativex was well-tolerated in the study, with the majority of adverse events being mild or moderate. In the study, Sativex demonstrated significant superiority
Under the terms of the licensing agreement, Ortho-Clinical Diagnostics and Novartis Vaccines and Diagnostics granted Roche Diagnostics a worldwide royalty-bearing license under their broad patent portfolio for hepatitis
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.